NCT03929978

Brief Summary

The aim of the non-interventional Post Market Clinical Follow-up (PMCF) study is to follow performance and safety of the newly marketed SenSura® Mio Baby device in a real-life setting. The objective is to evaluate the SenSura® Mio Baby device performance and safety.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2019

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 24, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 29, 2019

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 8, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 8, 2020

Completed
Last Updated

March 11, 2025

Status Verified

March 1, 2025

Enrollment Period

1.7 years

First QC Date

April 24, 2019

Last Update Submit

March 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Median wear time

    3 weeks

Eligibility Criteria

Age1 Week - 6 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The population in this study are (premature) infants over 30 weeks of gestation up to 6 months of age (calculated from term age meaning 40 GW) either with a colo- or, ileo-, or jejunostomy or a loop stoma, or two stomas placed closely together. Subjects can participate in the PMCF study if they fulfill the in-/exclusion criteria as listed in the tables below. However, the per protocol population include minimum 30 subjects from Group 1 or 2 as needed for the comparative performance evaluation.

You may qualify if:

  • Have a colostomy, ileostomy (jejunostomy), loop stoma, or two stomas placed closely together
  • Have given written informed consent (the legal authorized representative of the subject)

You may not qualify if:

  • The subjects are not allowed to participate in case they:
  • Are currently suffering from peristomal skin problems i.e. bleeding and/or broken skin (assessed by the investigator)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

0

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2019

First Posted

April 29, 2019

Study Start

January 1, 2019

Primary Completion

September 8, 2020

Study Completion

September 8, 2020

Last Updated

March 11, 2025

Record last verified: 2025-03